Complement therapeutics

Progress and trends in complement therapeutics -- Inhibition of the serine proteases of the complement system -- Role of MASP-1/3 in complement activation -- Membrane-bound complement regulatory proteins as biomarkers and potential therapeutic targets for SLE -- DAF as a therapeutic target for stero...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Körperschaft: International Complements Therapeutics Conference (VerfasserIn)
Weitere Verfasser: Lambris, John D. (HerausgeberIn), Holers, V. Michael (HerausgeberIn), Ricklin, Daniel (HerausgeberIn)
Format: UnknownFormat
Sprache:eng
Veröffentlicht: New York u.a. Springer 2013
Schriftenreihe:Advances in experimental medicine and biology volume 735
Schlagworte:
Online Zugang:Autorenbiografie
Verlagsangaben
Inhaltsverzeichnis
http://digitale-objekte.hbz-nrw.de/webclient/DeliveryManager?pid=4674642&custom_att_2=simple_viewer
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Progress and trends in complement therapeutics -- Inhibition of the serine proteases of the complement system -- Role of MASP-1/3 in complement activation -- Membrane-bound complement regulatory proteins as biomarkers and potential therapeutic targets for SLE -- DAF as a therapeutic target for steroid hormones: implications for host-pathogen interactions -- Targeting gC1qR domains for therapy against infection and inflammation -- Alternative C5a receptor function -- Effects of selective complement and CD14 inhibition on the E. coli-induced tissue factor mRNA upreglation, monocyte tissue factor expression, and tissue factor functional activity in human whole blood -- CR2-mediated targeting of complement inhibitors: bench-to-bedside using a novel strategy for site-specific complement modulation -- Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies -- Defective complement action and control defines disease pathology for retinal and renal disorders and provides a basis for new therapeutic approaches -- C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families -- Complement-targeted therapeutics in periodontitis -- Complement system activation in cardiac and skeletal muscle pathology: friend or foe? -- Innate immunity as orchestrator of bone marrow homing for hematopoietic stem/progenitor cells -- Complement-mediated microvascular injury leads to chronic rejection -- Targeting complement at the time of transplantation -- Evaluation of the blood compatibility of materials, cells, and tissues: basic concepts, test models, and practical guidelines -- Noninvasive detection of complement activation through radiologic imaging -- Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics -- Complement in action: an analysis of patent trends from 1976 through 2011.
Beschreibung:Includes bibliographical references and index
Beschreibung:VIII, 320 Seiten
Illustrationen
ISBN:9781461441175
978-1-4614-4117-5
146144117X
1-4614-4117-X